NEW YORK (AP) — A biotechnology set announced it has developed a system to decode an individual's DNA in a sunlight for $1,000, a long-sought cost goal for making the genome convenient for medical care.

Life Technologies Corp. declared Tuesday it was taking orders for the technology, which it expects to yield in about a year. The Carlsbad, Calif., congregation said three major research institutions had even now signed up for the $149,000 supernatural agency: the Baylor College of Medicine, the Yale School of Medicine and the Broad Institute of Cambridge, Mass.

A forward company, Illumina of San Diego, moreover introduced a new technology Tuesday that it reported will decode an entire genome in here and there 24 hours. Its statement did not computation the cost per genome.

The machines, called sequencers, relinquish scientists to identify the arrangement of the 3 billion chemical fabric blocks that make up someone's DNA.

Since the earliest sequencing of the basic human genome was announced at the White House in 2000, the costs of sequencing DNA accept steadily tumbled. The $1,000 target has long been cited as a explanation step toward making the technique adapted to practice for doctors to use to resist their patients, such as for revealing vulnerabilities to fixed diseases or tailoring medical treatment.

Sequencing unbroken genomes is now done primarily because research. It's different from the spiritual obedience some companies offer to consumers that countervail just part of the genome or critical spots in it, such as according to information on ancestry or disease excitability.

The $1,000 cost for a whole genome is about the same viewed like many of today's lab tests, said Chad Nussbaum, co-director of the Genome Sequencing and Analysis Program at the Broad Institute. Tuesday's declaration is "bringing the DNA sequence closer" to sentient affordable and fast enough for doctors to employment, Nussbaum said. If the machine works being of the kind which expected, a doctor might send a indulgent's DNA to a lab and be in possession of useful information back in about a week, he afore~.

Whether genomes from the new system will actually cost exactly $1,000 direction depend on how one calculates that shape, Nussbaum said. But even if it's accurate in the neighborhood, the technology could get widely adopted by doctors, he said.

Richard Gibbs, who directs the Human Genome Sequencing Center at Baylor, reported, "We will see if the machines veritably perform as well as described" in terms of cost and accuracy. "We're optimistic."

Nussbaum emphasized that uncovering a drown of DNA data about a long-suffering is one thing, and being versed to analyze it for useful accusation is quite another.

"You've got to collect the news out of the genome and you've got to accord. it to the doctor in a usable progress," he said. The ability to cheat that analysis is still "a developing anecdote," he said.

In the shorter denominate, the relatively low cost of the organization itself is important because it direction let more research laboratories get into DNA sequencing, Nussbaum afore~.

Shares of Life Technologies closed Tuesday at $46.17, up 8.3 percent.

___

Online:

Life Technologies: http://www.lifetechnologies.com

@yahoonews on Twitter, become a fan on Facebook